Case File
efta-efta00700880DOJ Data Set 9OtherFrom: "McCaffrey, Carlyn"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00700880
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "McCaffrey, Carlyn"
To: Jeffrey Epstein <[email protected]>
Subject: RE: Re:
Date: Mon, 11 Feb 2013 03:43:02 +0000
OK
Carlvn S. McCaffrey I Partner
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Sunday, February 10, 2013 10:36 PM
To: McCaffrey, Carlyn
Subject: Re:
Lets talk tomorw
On Sunday, February 10, 2013, McCaffrey, Carlyn wrote:
Where can you get prices? I didn't think there were any traded 10-year call options. What kind of price do you think
there would be for a 10-year call on with a strike price equal to a stock's current market price?
rairhin Ct Illeraffrau I Partnar
From: Jeffrey Epstein (main= emw
j
US
l guiSin
Sent: Sunday, February 10, 2013 6:29 PM
To: McCaffrey, Carlyn
Subject: Re:
e can actuallyl get prices. we could make them european, only excericable at expiration. etc. yes
On Sun, Feb 10, 2013 at 7:24 PM, McCaffrey, Carlyn
> wrote:
I know that the relationship between the strike price and current value are important factors in determining the
price of an option but aren't the length of the option and the volatility of the stock also very important? If there
are no 10 year publicly traded options we would have to get an appraisal.
Are you sure that a purchase be LB of the partnership interest followed by a sale by him of a call isn't caught by
16b?
On Feb 10, 2013, at 11:37 AM, "Jeffrey Epstein" <[email protected]> wrote:
1. according to the strike, price, 2. the economic effect can be manged in the document. 3, security wise lock
up is only concern as long as it happens near the same time and is not deep in the money, 4, the price of the
option reflects the risk of that,
On Sun, Feb 10, 2013 at 12:27 PM, McCaffrey, Carlyn <
> wrote:
EFTA00700880
What would the price of a 10 year option be?
Although he can buy the PS interest , the call will have to be on the stock itself.
Your structure bypasses 2703 because LB will never deliver the stock pursuant to the option. The economic
effect, however, is the same. That's why some think it doesn't work.
What are the securities law consequences of LB buying stock and the selling a call?
Does the purchaser of a publicly traded call risk the possibility that the stock value will not increase because all
the growth will be paid out in dividends?
On Feb 10, 2013, at 10:36 AM, "Jeffrey Epstein" <jeevacation®gmail.com> wrote:
good first try, yes call options are publicly traded, we would do five to ten year terms„ he could purchase
the partner ship interest i guess, valuation the issue , he could decide on how much, we wouldn't need to
bypass 2703, the stock would be full value but there would be an liability against it , which could not be
ignored. he would not need much money to live as he would have the full dividends.
On Sun, Feb 10, 2013 at 11:16 AM, McCaffrey, Carlyn <
> wrote:
I agree (although at least one of my partners does not) that you can avoid the reach of section 2703 with a cash settled
option.
How would we price the option? Are call options on the stock publicly traded? How are dividends treated under the
normal stock option?
Here's how I understand your proposal.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
EFTA00700881
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
IRS Circular 230 Disclosure: To comply with requirements imposed by the IRS, we inform you that any U.S. federal tax advice
contained herein (including any attachments), unless specifically stated otherwise, is not intended or written to be used, and
cannot be used, for the purposes of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or
recommending to another party any transaction or matter herein.
This message is a PRIVILEGED AND CONFIDENTIAL communication. This message and all attachments are a private
communication sent by a law firm and may be confidential or protected by privilege. If you are not the intended recipient, you
are hereby notified that any disclosure, copying, distribution or use of the information contained in or attached to this message
is strictly prohibited. Please notify the sender of the delivery error by replying to this message, and then delete it from your
system. Thank you.
Please visit http://www.mwe.com/ for more information about our Firm.
EFTA00700882
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.